Press Releases Archives - Page 23 of 103 - Lupin

BSE 2324.25 NSE 2324.50

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2324.25 NSE 2324.50

Lupin Receives Approval from TGA Australia for Tiotropium Dry Powder for Inhaler for Treatment of COPD

Lupin Digital Health and The American College of Cardiology Announce First-Of-Its-Kind Collaboration to Revolutionize In-home Cardiovascular Care in India with Digital Therapeutics

Lupin Receives Tentative Approval from U.S. FDA for Dolutegravir Lamivudine and Tenofovir Alafenamide Tablets

Lupin Launches Luforbec® 100/6 for Adult Asthma and COPD Treatment in Germany

Lupin Receives Approval from U.S. FDA for Chlorpromazine Hydrochloride Tablets USP

Lupin Receives EIR from U.S. FDA for its Pithampur Unit-2 Manufacturing Facility

Lupin Receives Tentative Approval from U.S. FDA for Dolutegravir Tablets for Oral Suspension

Lupin Receives Approval from U.S. FDA for Cyanocobalamin Nasal Spray

Lupin Announces Achievement of Key Milestone for its Phase 1 Clinical Stage MALT 1 inhibitor Program

Lupin Launches Rufinamide Oral Suspension in the United States

1 2 … 22 23 24 … 102 103

Search

Hit enter to search or ESC to close